Azoximer bromide

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Azoximer bromide
Azoximer bromide.svg
Systematic (IUPAC) name
Poly[[1-(carboxymethyl)piperazin-1-ium-1,4-diyl bromide]ethylene- co-[(piperazin-1,4-diyl 1-oxide)ethylene]]
Clinical data
Legal status
?
Pharmacokinetic data
Bioavailability up to 89%
Half-life 25.4 hours (intravenous routes)
Identifiers
CAS number 892497-01-7
ATC code L03AX
Synonyms Polyoxidonium, Synpol
Chemical data
Formula [[C8H15BrN2O2]x[C6H12N2O]y]n
Mol. mass 60000–100000 g/mol

Azoximer bromide is a macromolecular compound with high-molecular weight and high immunomodulating activity. It is for treatment and prophylaxis of diseases connected with damage of immune system. It is a N-oxidized polyethylene–piperazine derivative.

Azoximer bromide is registered in US Patent-5503830 from 1996,[1][2][3] in the Russian Federation from 1996, under registration number 96/302/9, FS 42-3906-00.[4]

References[edit]

  1. ^ http://www.google.com/patents/about?id=s9cfAAAAEBAJ&dq=US+5503830
  2. ^ http://www.wikipatents.com/US-Patent-5503830/compounds-having-immunostimulating-activity-and-methods-of-use-thereof
  3. ^ http://www.freepatentsonline.com/EP0789586.html
  4. ^ State Scientific Centre of Russian federation, Immunological Institute of Russian Federation Health Resort, CLINICAL ASPECTS OF USE OF IMMUNOMODULATOR POLYOXIDONIUM, Methodical handbook for doctors issued by State Scientific Centre of Russian Federation – Immunological Institute of Russian Federation Health Resort Moscow – 2003